Authors:
ABILDGAARD N
RUNGBY J
GLERUP H
BRIXEN K
KASSEM M
BRINCKER H
HEICKENDORFF L
ERIKSEN EF
NIELSEN JL
Citation: N. Abildgaard et al., LONG-TERM ORAL PAMIDRONATE TREATMENT INHIBITS OSTEOCLASTIC BONE-RESORPTION AND BONE TURNOVER WITHOUT AFFECTING OSTEOBLASTIC FUNCTION IN MULTIPLE-MYELOMA, European journal of haematology, 61(2), 1998, pp. 128-134
Authors:
BRINCKER H
WESTIN J
ABILDGAARD N
GIMSING P
TURESSON I
HEDENUS M
FORD J
KANDRA A
Citation: H. Brincker et al., FAILURE OF ORAL PAMIDRONATE TO REDUCE SKELETAL MORBIDITY IN MULTIPLE-MYELOMA - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL, British Journal of Haematology, 101(2), 1998, pp. 280-286
Authors:
MUNKSGAARD L
CHRISTENSEN BE
BRINCKER H
PEDERSEN NT
Citation: L. Munksgaard et al., CB CC DIFFUSE LYMPHOMA - A DISTINCT SUBTYPE OF NON-HODGKINS-LYMPHOMA - A STUDY OF 1593 PATIENTS FROM A DANISH POPULATION-BASED REGISTRY/, Annals of oncology, 8, 1997, pp. 25-28
Authors:
MORGAN G
VORNANEN M
PUITINEN J
NAUKKARINEN A
BRINCKER H
OLSEN J
COEBURGH JW
VRINTS LWMA
CLAYDEN D
MCNALLY R
JACK A
CARLI PM
PETRELLA T
TOMINO R
DLOLLO S
BARCHIELLI A
CARTWRIGHT R
Citation: G. Morgan et al., CHANGING TRENDS IN THE INCIDENCE OF NON-HODGKINS-LYMPHOMA IN EUROPE, Annals of oncology, 8, 1997, pp. 49-54
Authors:
SCHMIDT K
GRAMHANSEN P
BRINCKER H
CHRISTENSEN BE
ANDERSEN TM
JENSEN BA
Citation: K. Schmidt et al., REPEATED COURSES OF MITOXANTRONE AND HIGH-DOSE CYTOSINE-ARABINOSIDE SEEM TO CURE A SUBSTANTIAL PROPORTION OF AML PATIENTS LESS-THAN 60 YEARS, Blood, 88(10), 1996, pp. 852-852
Citation: H. Brincker et F. Damore, A RETROSPECTIVE ANALYSIS OF TREATMENT OUTCOME IN 106 CASES OF LOCALIZED GASTRIC NON-HODGKIN LYMPHOMAS, Leukemia & lymphoma, 18(3-4), 1995, pp. 281-288
Authors:
DAMORE F
BRINCKER H
GRONBAEK K
THORLING K
PEDERSEN M
JENSEN MK
ANDERSEN E
PEDERSEN NT
MORTENSEN LS
Citation: F. Damore et al., NON-HODGKINS-LYMPHOMA OF THE GASTROINTESTINAL-TRACT - A POPULATION-BASED ANALYSIS OF INCIDENCE, GEOGRAPHIC-DISTRIBUTION, CLINICOPATHOLOGICAL PRESENTATION FEATURES, AND PROGNOSIS, Journal of clinical oncology, 12(8), 1994, pp. 1673-1684
Citation: H. Brincker et Sm. Bentzen, A REANALYSIS OF AVAILABLE DOSE-RESPONSE AND TIME-DOSE DATA IN HODGKINS-DISEASE, Radiotherapy and oncology, 30(3), 1994, pp. 227-230
Citation: S. Cold et al., THE INFLUENCE OF CHEMOTHERAPY ON SURVIVAL AFTER RECURRENCE IN BREAST-CANCER - A POPULATION-BASED STUDY OF PATIENTS TREATED IN THE 1950S, 1960S AND 1970S, European journal of cancer, 29A(8), 1993, pp. 1146-1152
Citation: H. Brincker et Be. Christensen, ACUTE MUCOCUTANEOUS TOXICITY FOLLOWING HIGH-DOSE HYDROXYUREA, Cancer chemotherapy and pharmacology, 32(6), 1993, pp. 496-497